Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GABARAPL1 ELISA Kit (AC2903)
Cat.#: ASET-1492
Specifications
Description Human GABARAPL1 ELISA Kit allows for the in vitro quantitative determination of human GABARAPL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1050 Rat TSH beta ELISA Kit (AC2461) Quantitative inquiry ASET-1574 Human Galectin 3 ELISA Kit (AC2985) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry ASET-1220 Human CacyBP ELISA Kit (AC2631) Quantitative inquiry ASET-2126 Human LAMC2 ELISA Kit (AC3537) Quantitative inquiry ASET-1803 Human CPE ELISA Kit (AC3214) Quantitative inquiry ASET-1267 Human CHRM1 ELISA Kit (AC2678) Quantitative inquiry ASET-1205 Rat PON2 ELISA Kit (AC2616) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry ASET-2095 Rat Dopamine D2 Receptor ELISA Kit (AC3506) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket